Supriya Lifescience Ltd
₹655
(-1.15%)
Mon, 02 Mar 2026, 08:23 am
Supriya Lifescience Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 68.30 | 68.30 | 68.30 | 68.30 | 68.30 |
| FII | 5.20 | 5.46 | 6.78 | 7.19 | 6.52 |
| DII | 5.01 | 5.22 | 4.86 | 4.26 | 4.92 |
| Public | 21.50 | 21.02 | 20.06 | 20.26 | 20.26 |
| Government | 0 | 0 | 0 | 0 | 0 |
Supriya Lifescience Ltd Shareholding Pattern
The Supriya Lifescience Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Supriya Lifescience Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Supriya Lifescience Ltd (NSE: SUPRIYA, BSE: 543434) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Supriya Lifescience Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Supriya Lifescience Ltd Shareholding Pattern (Latest)
The latest Supriya Lifescience Ltd shareholding for Dec 2025 is:
- Promoters: 68.30%
- FII: 5.20%
- DII: 5.01%
- Public: 21.50%
- Government: 0%
Promoter holding in Supriya Lifescience Ltd remains stable, reflecting consistent long-term commitment.
Supriya Lifescience Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Supriya Lifescience Ltd.
- Dec 2025: 68.30%
- Sept 2025: 68.30%
- Jun 2025: 68.30%
- Mar 2025: 68.30%
- Dec 2024: 68.30%
Promoter stake remains largely stable, showing consistent ownership structure.
Supriya Lifescience Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Supriya Lifescience Ltd.
- Dec 2025: 5.20%
- Sept 2025: 5.46%
- Jun 2025: 6.78%
- Mar 2025: 7.19%
- Dec 2024: 6.52%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Supriya Lifescience Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Dec 2025: 5.01%
- Sept 2025: 5.22%
- Jun 2025: 4.86%
- Mar 2025: 4.26%
- Dec 2024: 4.92%
DII holdings remain stable, reflecting steady institutional participation.
Supriya Lifescience Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Dec 2025: 21.50%
- Sept 2025: 21.02%
- Jun 2025: 20.06%
- Mar 2025: 20.26%
- Dec 2024: 20.26%
Public participation in Supriya Lifescience Ltd has increased, indicating rising retail investor interest.
Supriya Lifescience Ltd Government Holding
Government holding in Supriya Lifescience Ltd currently stands at 0%.
Supriya Lifescience Ltd operates without significant government ownership.
Supriya Lifescience Ltd Shareholding Analysis Summary
The Supriya Lifescience Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Supriya Lifescience Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Supriya Lifescience Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800